Pfizer

US FDA Prepares for Crucial COVID-19 Decision

by

As we navigate the ongoing evolution of respiratory viruses, the focus of global health regulators remains steadfast on adapting public health interventions to meet current viral threats. Recently, discussions regarding the potential development of a new COVID-19 vaccine formulation have centered on the need to address emerging variants, a process that relies heavily on the … Read more

Can Pfizer’s Pipeline Replace Lost COVID Revenue & Patent Cliffs?

by

Berlin – Pharmaceutical giant Pfizer faces a critical juncture as it navigates a post-COVID revenue landscape and patent expirations. The company is actively reshaping its research and development pipeline, with a renewed focus on oncology, obesity, and other therapeutic areas, including heart failure. This strategic shift aims to ensure sustained growth and innovation in the … Read more